{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T19:45:25Z","timestamp":1785008725887,"version":"3.55.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0013517","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000}}],"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>\n                    Bat HKU5-CoV-2 (BtHKU5-CoV-2), a recently discovered bat-infecting merbecovirus, was found to infect human cell lines by utilizing the human angiotensin-converting enzyme 2 (ACE2) receptor, similar to SARS-CoV-2, which caused millions of deaths. Moreover, its broad host tropism has raised significant concerns about potential human spillover risk. Therefore, there is an urgent need to develop vaccines to combat the potential outbreak of BtHKU5-CoV-2. However, research focusing on BtHKU5-CoV-2 remains limited. In this study, we designed a novel multi-epitope vaccine for BtHKU5-CoV-2 using an immunoinformatics approach. Eight cytotoxic T lymphocyte (CTL) epitopes, seven helper T lymphocyte (HTL) epitopes, and five linear B lymphocyte (LBL) epitopes were screened from the spike glycoprotein of BtHKU5-CoV-2. The selected epitopes were joined together with appropriate linkers, and \u03b2-defensin II and MHC I-targeting domain (MITD) were incorporated into the construct to enhance vaccine immunogenicity.\n                    <jats:italic>In silico<\/jats:italic>\n                    analyses suggested that the designed vaccine may have favorable predicted antigenicity and immunogenicity while being non-toxic and non-allergenic. The tertiary structure of the multi-epitope vaccine was modeled and refined, and its structural plausibility was evaluated using\n                    <jats:italic>in silico<\/jats:italic>\n                    quality metrics. Molecular docking studies suggested plausible interaction modes between the vaccine construct and Toll-like receptor 2 (TLR2) and TLR4. Moreover, the mRNA was predicted to show potential interaction modes with TLR3, TLR7, and TLR8 receptors. Additionally,\n                    <jats:italic>in silico<\/jats:italic>\n                    immune simulations suggested that vaccination may elicit humoral and cellular immune responses. Collectively, these computational results suggest that the proposed mRNA vaccine is a potential candidate for BtHKU5-CoV-2. However, further experiments are necessary to validate its protective efficacy.\n                  <\/jats:p>","DOI":"10.1371\/journal.pntd.0013517","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T17:42:11Z","timestamp":1775238131000},"page":"e0013517","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["In silico design of a novel multi-epitope mRNA vaccine candidate for BtHKU5-CoV-2 using immunoinformatics"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1065-6586","authenticated-orcid":true,"given":"Ningze","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"issue":"6","key":"pntd.0013517.ref001","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.01.042","article-title":"Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor","volume":"188","author":"J Chen","year":"2025","journal-title":"Cell"},{"issue":"1","key":"pntd.0013517.ref002","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"F Li","year":"2016","journal-title":"Annu Rev Virol"},{"issue":"7","key":"pntd.0013517.ref003","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41579-025-01185-8","article-title":"SARS-CoV-2 spike protein: structure, viral entry and variants","volume":"23","author":"B Chen","year":"2025","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"pntd.0013517.ref004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"CB Jackson","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"pntd.0013517.ref005","doi-asserted-by":"crossref","first-page":"102838","DOI":"10.1016\/j.tmaid.2025.102838","article-title":"HKU5-CoV-2: A silent threat looming in bats","volume":"65","author":"S Srivastava","year":"2025","journal-title":"Travel Med Infect Dis"},{"key":"pntd.0013517.ref006","doi-asserted-by":"crossref","first-page":"101611","DOI":"10.1016\/j.nmni.2025.101611","article-title":"HKU5-CoV lineage 2 (HKU5-CoV-2): A novel bat-infecting coronavirus with likely \u201cspillover\u201d risk","volume":"66","author":"H Karami","year":"2025","journal-title":"New Microbes New Infect"},{"issue":"8","key":"pntd.0013517.ref007","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1097\/JS9.0000000000002614","article-title":"Discovery of a novel coronavirus lineage HKU5-CoV-2 (Merbecovirus lineage 2) raises concerns: possible global threat or a fear?","volume":"111","author":"RK Mohapatra","year":"2025","journal-title":"Int J Surg"},{"issue":"12","key":"pntd.0013517.ref008","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S1473-3099(23)00373-0","article-title":"Effectiveness of bivalent mRNA vaccines against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study","volume":"23","author":"CY Tan","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"pntd.0013517.ref009","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases - advances, challenges and opportunities","volume":"23","author":"N Pardi","year":"2024","journal-title":"Nat Rev Drug Discov"},{"issue":"16","key":"pntd.0013517.ref010","doi-asserted-by":"crossref","first-page":"15231","DOI":"10.1021\/acsnano.2c12584","article-title":"The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology","volume":"17","author":"Z Ye","year":"2023","journal-title":"ACS Nano"},{"key":"pntd.0013517.ref011","doi-asserted-by":"crossref","first-page":"1497580","DOI":"10.3389\/fcimb.2024.1497580","article-title":"Multi-epitope vaccines: a promising strategy against viral diseases in swine","volume":"14","author":"X Chen","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"104","key":"pntd.0013517.ref012","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ado5937","article-title":"Linking vaccine adjuvant mechanisms of action to function","volume":"10","author":"E Ben-Akiva","year":"2025","journal-title":"Sci Immunol"},{"issue":"1","key":"pntd.0013517.ref013","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10709","article-title":"MHCI trafficking signal-based mRNA vaccines strengthening immune protection against RNA viruses","volume":"10","author":"Y Zhang","year":"2024","journal-title":"Bioeng Transl Med"},{"issue":"1","key":"pntd.0013517.ref014","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1038\/s41467-025-58328-x","article-title":"An mRNA vaccine against monkeypox virus inhibits infection by co-activation of humoral and cellular immune responses","volume":"16","author":"W Tai","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"pntd.0013517.ref015","doi-asserted-by":"crossref","first-page":"2377606","DOI":"10.1080\/22221751.2024.2377606","article-title":"A long-term stable cold-chain-friendly HIV mRNA vaccine encoding multi-epitope viral protease cleavage site immunogens inducing immunogen-specific protective T cell immunity","volume":"13","author":"S Mandal","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"pntd.0013517.ref016","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/1471-2105-8-424","article-title":"Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction","volume":"8","author":"MV Larsen","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"pntd.0013517.ref017","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"IA Doytchinova","year":"2007","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"pntd.0013517.ref018","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v.2--a server for in silico prediction of allergens","volume":"20","author":"I Dimitrov","year":"2014","journal-title":"J Mol Model"},{"issue":"5","key":"pntd.0013517.ref019","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac174","article-title":"ToxinPred2: an improved method for predicting toxicity of proteins","volume":"23","author":"N Sharma","year":"2022","journal-title":"Brief Bioinform"},{"issue":"10","key":"pntd.0013517.ref020","article-title":"Properties of MHC class I presented peptides that enhance immunogenicity","volume":"9","author":"JJA Calis","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"pntd.0013517.ref021","article-title":"TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates","volume":"114","author":"S Paul","year":"2016","journal-title":"Curr Protoc Immunol"},{"issue":"6","key":"pntd.0013517.ref022","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/acs.jproteome.9b00874","article-title":"Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data","volume":"19","author":"B Reynisson","year":"2020","journal-title":"J Proteome Res"},{"key":"pntd.0013517.ref023","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"SK Dhanda","year":"2013","journal-title":"Biol Direct"},{"key":"pntd.0013517.ref024","doi-asserted-by":"crossref","first-page":"263952","DOI":"10.1155\/2013\/263952","article-title":"Prediction of IL4 inducing peptides","volume":"2013","author":"SK Dhanda","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"pntd.0013517.ref025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"S Saha","year":"2006","journal-title":"Proteins"},{"key":"pntd.0013517.ref026","article-title":"Protein structure prediction and analysis using the Robetta server","volume":"32","author":"DE Kim","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"pntd.0013517.ref027","article-title":"GalaxyWEB server for protein structure prediction and refinement","volume":"40","author":"J Ko","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"pntd.0013517.ref028","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"M Wiederstein","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"pntd.0013517.ref029","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"J Ponomarenko","year":"2008","journal-title":"BMC Bioinformatics"},{"issue":"164","key":"pntd.0013517.ref030","doi-asserted-by":"crossref","first-page":"210274","DOI":"10.1183\/16000617.0274-2021","article-title":"Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell","volume":"31","author":"JLN Girkin","year":"2022","journal-title":"Eur Respir Rev"},{"key":"pntd.0013517.ref031","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1107\/S2059798322002741","article-title":"Elucidation of protein function using computational docking and hotspot analysis by ClusPro and FTMap","volume":"78","author":"G Jones","year":"2022","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"pntd.0013517.ref032","article-title":"iMODS: internal coordinates normal mode analysis server","volume":"42","author":"JR L\u00f3pez-Blanco","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"pntd.0013517.ref033","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"H-H Bui","year":"2006","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"pntd.0013517.ref034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"N Rapin","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"pntd.0013517.ref035","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","article-title":"Decoding Toll-like receptors: Recent insights and perspectives in innate immunity","volume":"57","author":"T Kawai","year":"2024","journal-title":"Immunity"},{"issue":"25","key":"pntd.0013517.ref036","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra032498","article-title":"The severe acute respiratory syndrome","volume":"349","author":"JSM Peiris","year":"2003","journal-title":"N Engl J Med"},{"issue":"7807","key":"pntd.0013517.ref037","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"J Shang","year":"2020","journal-title":"Nature"},{"issue":"4","key":"pntd.0013517.ref038","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/med.20055","article-title":"Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention","volume":"26","author":"K-S Yeung","year":"2006","journal-title":"Med Res Rev"},{"issue":"6","key":"pntd.0013517.ref039","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cell.2021.02.030","article-title":"Novel approaches for vaccine development","volume":"184","author":"MS Gebre","year":"2021","journal-title":"Cell"},{"issue":"1","key":"pntd.0013517.ref040","article-title":"Development of a novel multi-epitope mRNA vaccine candidate to combat SFTSV pandemic","volume":"19","author":"F Zhu","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pntd.0013517.ref041","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00809-24","article-title":"mRNA vaccine design using the proteome of Theileria annulata through immunoinformatics approaches","volume":"10","author":"R Fattahi","year":"2025","journal-title":"mSphere"},{"issue":"5595","key":"pntd.0013517.ref042","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.1075565","article-title":"Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2","volume":"298","author":"A Biragyn","year":"2002","journal-title":"Science"},{"issue":"2","key":"pntd.0013517.ref043","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1158\/0008-5472.CAN-05-2891","article-title":"Vaccine with beta-defensin 2-transduced leukemic cells activates innate and adaptive immunity to elicit potent antileukemia responses","volume":"66","author":"X-T Ma","year":"2006","journal-title":"Cancer Res"},{"key":"pntd.0013517.ref044","doi-asserted-by":"crossref","first-page":"884433","DOI":"10.3389\/fimmu.2022.884433","article-title":"Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches","volume":"13","author":"M Yu","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"pntd.0013517.ref045","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.3390\/microorganisms9091820","article-title":"TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection","volume":"9","author":"D Bortolotti","year":"2021","journal-title":"Microorganisms"},{"key":"pntd.0013517.ref046","doi-asserted-by":"crossref","first-page":"1460089","DOI":"10.3389\/fimmu.2025.1460089","article-title":"Cyclophilin-CD147 interaction enables SARS-CoV-2 infection of human monocytes and their activation via Toll-like receptors 7 and 8","volume":"16","author":"G Tajti","year":"2025","journal-title":"Front Immunol"},{"key":"pntd.0013517.ref047","doi-asserted-by":"crossref","first-page":"1118267","DOI":"10.3389\/fimmu.2023.1118267","article-title":"Immunoinformatics lessons on the current COVID-19 pandemic and future coronavirus zoonoses","volume":"14","author":"D L\u00f3pez","year":"2023","journal-title":"Front Immunol"},{"issue":"10","key":"pntd.0013517.ref048","article-title":"Broad-spectrum vaccines against various and evolving viruses: from antigen design to nanoparticle delivery","volume":"99","author":"M Cao","year":"2025","journal-title":"J Virol"},{"key":"pntd.0013517.ref049","doi-asserted-by":"crossref","first-page":"1417065","DOI":"10.3389\/fitd.2024.1417065","article-title":"Disease X in the tropics, preventing the next pandemic: how to accelerate spillover prevention and vaccine preparedness?","volume":"5","author":"C Possas","year":"2024","journal-title":"Front Trop Dis"},{"issue":"12","key":"pntd.0013517.ref050","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41577-021-00567-2","article-title":"Using cross-species vaccination approaches to counter emerging infectious diseases","volume":"21","author":"GM Warimwe","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"pntd.0013517.ref051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008607","article-title":"In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction","volume":"16","author":"S Silva-Arrieta","year":"2020","journal-title":"PLoS Pathog"},{"issue":"1","key":"pntd.0013517.ref052","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/s42003-024-07292-1","article-title":"Geometric deep learning improves generalizability of MHC-bound peptide predictions","volume":"7","author":"DF Marzella","year":"2024","journal-title":"Commun Biol"},{"issue":"4","key":"pntd.0013517.ref053","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"N Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"pntd.0013517.ref054","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"N Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"pntd.0013517.ref055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","article-title":"COVID-19 vaccine development: milestones, lessons and prospects","volume":"7","author":"M Li","year":"2022","journal-title":"Signal Transduct Target Ther"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0013517","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:41:49Z","timestamp":1775756509000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013517"}},"subtitle":[],"editor":[{"given":"Prashant","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013517","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]}}}